BGB-8035 is an orally active, highly selective brutons tyrosine kinase (BTK) inhibitor with IC50s of 1.1 nM, 99 nM, 621 nM for BTK, TEC, EGFR, respectively. BGB-8035 has antitumor and anti-arthritis activity. BGB-8035 has the potential for B-cell maligna
Molecular Weight:
453.53
CAS Number:
[2283349-24-4]
Formula:
C24H31N5O4
Target:
Btk
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted